Location History:
- Sumter, SC (US) (1996)
- Edmonds, WA (US) (1989 - 1998)
- Ellensburg, WA (US) (2012 - 2022)
- Seattle, WA (US) (2017 - 2023)
Company Filing History:
19 out of 19 
4 out of 8 
2 out of 11 Years Active: 1989-2025
Title: Innovations in Vaccination: The Contributions of Frank R Jones
Introduction
Frank R Jones, based in Seattle, WA, is an accomplished inventor renowned for his significant contributions to the field of immunology and vaccine development. With a remarkable portfolio of 24 patents, Jones has been at the forefront of innovative technologies that enhance vaccination strategies, particularly utilizing adenovirus vectors.
Latest Patents
Among his latest patents are methods and compositions for producing an adenovirus vector designed for use with multiple vaccinations. These methods focus on generating immune responses using adenovirus vectors that allow for repeated vaccinations with the same vector, catering to individuals who may have existing immunity to adenovirus. This innovation is poised to make a considerable impact on vaccination efficacy and accessibility.
Career Highlights
Throughout his career, Frank R Jones has played pivotal roles in two notable companies: Etubics Corporation and Imre Corporation. His work at these organizations has furthered research into vaccine development, solidifying his reputation as a key innovator in this critical field.
Collaborations
Jones has also collaborated with esteemed professionals such as Joseph P Balint and Elizabeth Gabitzsch. These partnerships have fostered a productive environment for research and development, leading to advancements in the technologies surrounding adenovirus-based vaccines.
Conclusion
Frank R Jones exemplifies the spirit of innovation in the realm of vaccine development. With his extensive patent portfolio and collaborative efforts, he continues to pave the way for groundbreaking advancements that have the potential to transform public health and improve vaccination strategies worldwide.